Aneurysmal subarachnoid haemorrhage in a patient with thyrotoxicosis

British Journal of Neurosurgery

Volumn 20, Issue 3, 2006, Pages 165-168

  Bhatia, R ^a,b   Hughes, D ^a   Crocker, M ^a   Strong, A ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Delayed ischaemic neurological deficit; Subarachnoid haemorrhage; Thyrotoxicosis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBIMAZOLE; PROPRANOLOL;

ADULT; ANEURYSM RUPTURE; ARTICLE; BRAIN PERFUSION; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG WITHDRAWAL; HUMAN; HYPOTENSION; INTRACRANIAL ANEURYSM; MALE; MEDICAL DECISION MAKING; PATIENT SAFETY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SUBARACHNOID HEMORRHAGE; THYROTOXICOSIS; TREATMENT OUTCOME; TREATMENT PLANNING; VASOSPASM;

ADULT; ANEURYSM, RUPTURED; HUMANS; INTRACRANIAL ANEURYSM; MALE; SUBARACHNOID HEMORRHAGE; THYROTOXICOSIS; TOMOGRAPHY, X-RAY COMPUTED; VASOSPASM, INTRACRANIAL;

EID: 33745726750     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.1080/02688690600777133     Document Type: Article

References (13)

1. Awad I, Carter L, Spetzler R, Medina M, Williams F. Clinical vasospasm after subarachnoid haemorrhage: response to hypervolaemic haemodilution and arterial hypertension. Stroke 1987;18:365-72.
2. Walton J. Subarachnoid haemorrhage. Edinburgh: Churchill Livingstone; 1956.
3. Casson I, Cooke N. Thyrotoxicosis and subarachnoid haemorrhage. Br J Clin Prac 1981;35:121-2.
4. Selo-Ojeme D, Lag M, Ikomi A, Ojutiku D, Aspoas R, Chawda S, et al. Aneurysmal subarachnoid haemorrhage during pregnancy. Eur J Obstet Gynaecol Rep Biol 2004;116:131-43.
5. Dias M, Sekhar L. Intracranial aneurysms from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery 1990;7:855-66.
6. Stehbens W. Aetiology of cerebral aneurysms. Lancet 1981;2:524-5.
7. Hamann G, Haass A, Schimrigk K. Beta-blockade in acute aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 1993;121:119-22.
8. Neil-Dwyer G, Walter P, Cruickshank J. Beta-blockade benefits patients following a subarachnoid haemorrhage. Eur J Clin Pharmacol 1985;28(Suppl.):25-9.
9. Kassell N, Peerless S, Durward Q, Beck D, Drake CHA. Treatment of ischaemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982;11:337-43.
10. Origitano T, Wascher T, Reichman ODA. Sustained increase cerebral blood flow with prophylactic hypertensive hypervolaemic haemodilution ("triple H" therapy) after subarachnoid haemorrhage. Neurosurgery 1990;27:729-40.
11. Strong A, Wyke M, Daum I, Darkins A, Volans A. The Maudsley Mentation Test: A method for extended monitoring of mental status after aneurysmal subarachnoid haemorrhage. Neurosurgery 1992;31:886-90.
12. Hoeffner E, Case I, Jain R, Gujar S, Shah G, Deveikis J, et al. Cerebral perfusion CT: technique and clinical applications. Radiology 2004;231:632-44.
13. Harrigan M, Magnano C, Guterman L, Hopkins L. Computed tomographic perfusion in the management of aneurysmal subarachnoid haemorrhage: New application of an existent technique. Neurosurgery 2005;56:304-17.